Marino I R, Scantlebury V P, Bronsther O, Iwatsuki S, Starzl T E
Department of Surgery, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Transpl Int. 1992;5 Suppl 1(Suppl 1):S201-5. doi: 10.1007/978-3-642-77423-2_64.
Extensive hepatocellular adenomatosis (HA) and focal nodular hyperplasia (FNH) represent a proliferation of hepatic cells that occurs most frequently in women. These lesions are uncommon in the pediatric age group, accounting for 2% of pediatric hepatic tumors, and are extremely rare in males. The etiology of HA and FNH has been correlated with the use of oral contraceptives. We report to the best of our knowledge the first series of patients treated with OLTx for HA and FNH (five cases). All these patients had lesions involving at least 90% of the hepatic parenchyma and all underwent major hepatic surgery before OLTx because of life threatening complications. One patient died in the immediate postoperative period following retransplantation for primary non-function of the first OLTx. Four out of five patients are currently alive from 4.1 to 9.6 years after OLTx. Our results justify the use of OLTx for symptomatic patients with HA and FNH who cannot be treated with conventional hepatic resections.
广泛的肝细胞腺瘤病(HA)和局灶性结节性增生(FNH)是肝细胞的一种增殖性病变,最常见于女性。这些病变在儿童年龄组中并不常见,占儿童肝肿瘤的2%,在男性中极为罕见。HA和FNH的病因与口服避孕药的使用有关。据我们所知,我们报告了首例接受肝移植治疗HA和FNH的系列病例(5例)。所有这些患者的病变至少累及90%的肝实质,并且由于危及生命的并发症,在肝移植前均接受了大型肝脏手术。1例患者在首次肝移植原发性无功能后再次移植的术后即刻死亡。5例患者中有4例目前在肝移植后4.1至9.6年仍存活。我们的结果证明,对于无法通过传统肝切除术治疗的有症状的HA和FNH患者,肝移植是合理的。